Promoting lung cancer screening of high‐risk patients by primary care providers

Author:

Colamonici Marco12ORCID,Khouzam Nader12,Dell Catherine1,Auge‐Bronersky Kristin12,Pacheco Esther12,Rubinstein Israel12,Recht Bradley12

Affiliation:

1. Medical Service Jesse Brown Veterans Affairs Medical Center Chicago Illinois USA

2. Department of Medicine University of Illinois College of Medicine at Chicago Chicago Illinois USA

Abstract

AbstractBackgroundLung cancer screening (LCS) with low‐dose computed tomography (LDCT) of the chest of eligible patients remains low. Accordingly, augmentation of appropriate LCS referrals by primary care providers (PCPs) was sought.MethodsThe quality improvement (QI) project was performed between April 2021 and June 2022. It incorporated patient education, shared decision‐making (SDM) with PCPs, and tracking of initial LDCT completion. In each case, lag time (LT) to LCS and pack‐years (PYs) were calculated from initial LCS eligibility. The cohort’s scores were compared to national scores. Patient zip codes were used to create a geographic map of our cohort for comparison with public health data.ResultsAn immediate and sustained increase in weekly LCS referrals from PCPs was recorded. Of 337 initial referrals, 95% were men, consisting of 66.2% Black, 28.4% White, and 5.4% other. Mean PY was less for minorities (45.3 vs. 37.3 years; p = .0002) but mean LT was greater for Whites (7.9 vs. 6.2 years; p = .03). Twenty‐five percent of veterans failed to report to their scheduled screening, and two declined referrals. Notably, most no‐show patients lived in transit deserts. Furthermore, Lung‐RADS scores 4B/4X were more than double the expected prevalence (p = .008).ConclusionsThe PCPs in this study successfully augmented LCS referrals. A substantial proportion of these patients were no‐shows, and our data suggest complex racial and socioeconomic factors as contributing variables. In addition, a higher‐than‐expected number of initial Lung‐RADS scores 4B/4X were reported. A large, multisite QI project is warranted to address overcoming potential transportation barriers in high‐risk patient populations.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference39 articles.

1. Lung Cancer Worldwide

2. State of Lung Cancer.2021.American Lung Association.https://www.lung.org/research/state‐of‐lung‐cancer

3. Cancer Stat Facts: Lung and Bronchus Cancer.2022. Surveillance Epidemiology and End Results Program. Accessed March 25 2023.https://seer.cancer.gov/statfacts/html/lungb.html

4. Cancer statistics, 2023

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3